Moscow, December, 11 2012 – Pharmstandard OJSC (LSE: PHST IL, MICEX-RTS: PHST RU), Russia’s leading pharmaceutical company, announces the signing of a partnership agreement with AVVA Rus OJSC.

On December 10, 2012 Pharmstandard OJSC and AVVA Rus OJSC signed a partnership agreement for manufacturing, promotion and distribution of the following product brands in Russia: Mikrazim®, Filtrum®, Laktofiltrum® and Ursogliv®.

This partnership agreement will allow to offer the most attractive terms of shipment to distributors and pharmacy chains, as well as to implement a successful marketing strategy.

Pharmstandard OJSC informs that it has no further M&A plans for the rest of 2012. The Company made 2 acquisitions this year – 50.1% in Big Pearl Trading Ltd. and 100% in LEKKO OJSC. Total sum of investments does not exceed $80m.